PF-0713
Modify Date: 2025-08-25 09:53:21
PF-0713 structure
|
Common Name | PF-0713 | ||
|---|---|---|---|---|
| CAS Number | 1083093-47-3 | Molecular Weight | 206.32 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H22O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PF-0713PF 0713, a GABAA receptor agonist, is used as an intravenous sedative-hypnotic for general anaesthesia, ICU sedation, procedural sedation, chemotherapy. |
| Name | PF-0713 |
|---|
| Description | PF 0713, a GABAA receptor agonist, is used as an intravenous sedative-hypnotic for general anaesthesia, ICU sedation, procedural sedation, chemotherapy. |
|---|---|
| References | 1. Chitilian HV, Eckenhoff RG, Raines DE. Anesthetic drug development: Novel drugs and new approaches. Surg Neurol Int. 2013 Mar 19;4(Suppl 1):S2-S10. doi: 10.4103/2152-7806.109179. Print 2013. PubMed PMID: 23653886; PubMed Central PMCID: PMC3642742. |
| Molecular Formula | C14H22O |
|---|---|
| Molecular Weight | 206.32 |
| InChIKey | FHTGJZOULSYEOB-GHMZBOCLSA-N |
| SMILES | CCC(C)c1cccc(C(C)CC)c1O |